The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFC Energy Regulatory News (AFC)

Share Price Information for AFC Energy (AFC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.60
Bid: 18.12
Ask: 18.74
Change: 0.42 (2.31%)
Spread: 0.62 (3.422%)
Open: 18.18
High: 18.74
Low: 17.70
Prev. Close: 18.18
AFC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

1 Mar 2021 07:00

RNS Number : 5832Q
AFC Energy Plc
01 March 2021
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

1 March 2021

AFC Energy plc

("AFC Energy" or the "Company")

Final Results for year ended 31 October 2020

AFC Energy (AIM: AFC), a leading provider of hydrogen power generation technologies, is pleased to announce its results for the year ended 31 October 2020. Highlights of those results are as follows.

 

Commercial

 

· Six-month engagement with global e-mobility leader, ABB, culminating in the post year-end formation of a Strategic Partnership to develop high power Electric Vehicle (EV) charging solutions with established route to a growing worldwide EV market.

 

· Achieved first commercial orders, including appointment as Official Charging Partner of FIA Accredited Extreme E in 2021, providing sustainable off-grid power for rapid vehicle charging.

 

· Confirmed initial order book of £1.1m at year end, with strong pipeline of commercial orders across prospective partners and distributors currently under development.

 

· Announced collaboration with global contractor ACCIONA, highlighting opportunities for sustainable construction and temporary power applications.

 

· Introduced potential for alkaline fuel cell adoptions in high growth micro grid applications with system sale to Forschungszentrum Jülich ("Jülich") at its Living Lab Energy Campus ("LLEC") showcase in Germany.

 

· Commenced strategic relationship with Ricardo plc post year-end to explore alkaline fuel cell deployment across global maritime, rail and stationary markets following growth in enquiries - all new target industries for the business.

 

· Oversubscribed £31.6m fundraise, strengthening balance sheet for accelerated growth.

 

Manufacturing

 

· Confirmation of capital light manufacturing and scale up strategy through supply chain strengthening in preparation for near term growth potential in commercial orders.

 

· Cemented partnership with BK Gulf through post year-end agreement for mass scale up of containerised and skid mounted fuel cell system fabrication.

 

· Agreement reached post year-end to lease 30,000 sq. ft UK based facility for the assembly, commissioning and dispatch of fuel cell systems to customers.

 

Technology

 

· Prototype design of high-density "S" series fuel cell system completed and work commenced to assemble and demonstrate "short stack" performance, prior to scaling up to full scale 10kW stack in 2021 and expected release of commercial-scale stacks to the market in late 2022.

 

· Initial supply of AlkaMem® membrane samples across multiple non-fuel cell applications demonstrating the diversity of revenue opportunities across non-core markets.

 

· Design and engineering of world class testing and research lab for high density fuel cell, launched after year-end in February 2021.

 

Key Financial Highlights

 

· Stronger year end cash balance of £31.6m (FY 2019: £1.6m), providing the basis for future growth.

 

· Growing investment in product range reflected in increased loss of £4.2m (FY 2019: £2.9m).

 

· Strong pipeline growth across all target markets post year-end with potential for commensurate revenue.

 

 

Outlook

 

· Unprecedented global investment in hydrogen, with $300bn project pipeline and 30 of the world's largest economies already having national Hydrogen strategies in place.

 

· Principle of 'building back better' and the bringing forward of EV deployment post COVID-19 is driving strong Government action on decarbonisation.

 

· Leveraging the value of existing and new international partnerships to enhance commercial route to market remains central to driving growth in top line commercial revenue.

 

· Systems to be completed and deployed to reinforce political & regulatory support for industry's viable transition away from diesel, with anticipated drive towards commercial sales.

· Stronger balance sheet to support further investment in containerised fuel cell systems to meet customer demand and hone supply chain and manufacturing scale up potential.

 

· Planned deployment of first integrated EV charger system alongside ABB in second half of 2021.

 

· Target delivery of first prototype high energy density "S" series fuel cell stack with adoption of AFC Energy's new Alkamem® membrane technology in 2021.

 

· Continued international promotion of our work through the Hydrogen Council and the Ammonia Energy Association.

 

Adam Bond, Chief Executive of AFC Energy, said:

 

"2020 was the year that hydrogen took centre stage as a key enabler of a more sustainable future, fuelling a transformational year for AFC Energy. A growing order book, new strategic partnerships, a stronger cash position at year-end and a strong global political will, evidenced by record levels of investment in the sector, provides the basis for our future success.

 

Our outlook for the coming year is one of confidence, with both Governmental policies and industry sentiment driving sustainable change in our key target markets. The Company's stronger balance sheet position enables us to invest in our people, products and technology and we therefore expect cash burn to increase in the coming year to deliver and grow our order book.

 

Leveraging the value of our existing international partnerships and collaborations remains central to our approach in 2021. With the required distribution channels, manufacturing and staffing being put in place to turn our enquiry pipeline into commercial sales with significant annuity revenue, I look forward to us making a growing contribution to delivering emissions-free solutions to the world's energy challenges."

 

-ENDS-

AFC Energy plc

Adam Bond (Chief Executive Officer)  

Iain Thomson (Head of Communications and Stakeholder Management)

+44 (0) 14 8327 6726

Investors@afcenergy.com

 

WH Ireland Nominated Adviser and Joint Broker

Mike Coe (Corporate Finance)

Jasper Berry (Corporate Broking)

+44 (0) 117 945 3470

 

 

M C Peat & Co LLP - Joint Broker

Charlie Peat

+44 (0) 20 7104 2334

Zeus Capital Limited - Joint Broker

Daniel Harris (Corporate Finance)

John Goold/Dominic King (Corporate Broking)

+44 (0) 203 829 5000

 

Tuva Partners - Public Relations

Alex Brooks

+44 (0) 7900 205 460

For further information, please contact:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

About AFC Energy plc

AFC Energy plc is commercialising a scalable alkaline fuel cell system, to provide clean electricity for on and off grid applications. The technology is now deployable in electric vehicle chargers, off-grid decentralised power systems and industrial gas plants as part of a portfolio approach to the decarbonisation of local electricity needs (Afcenergy.com).

Chairman's report

 

The year ended 31 October 2020 was a transformational one for AFC Energy. A supportive public policy environment, commercial opportunity, strong customer engagement and product readiness all converged and gave rise to our first commercial orders. The profile of the company was also significantly heightened through becoming the official charging partner for the inaugural Extreme E season, alongside the forging of close ties with global partners in the EV Charging (ABB) and Construction (Acciona) markets to grow our international footprint and reputation.

 

The successful £31.6m fundraising that took place in July was also a critical milestone in the development of the company, directly supporting the transition from the development of our products and technology into the manufacture and commercialisation of them whilst providing significant financial headroom for long-term planning. The company is in a strong position for future growth.

 

Financial Overview

 

The successful restructuring of our finances in this financial year provides a robust platform to accelerate the deployment of our products into our key target markets. The year began with several small fundraises which avoided the need for a drawdown from our £4m convertible loan facility and provided sufficient liquidity for the company to deliver against our customer commitments during the first lockdown.

 

The successful conclusion of our July fundraise brought the total funds raised for the year to £34 million. Careful use of this funding prior to period end meant that we ended the year with a cash balance of £31.6 million (FY 2019: £1.6 million). This strong cash position supported our decision after period end to cancel our Convertible Loan Note facility, having not drawn any amounts from it during the eighteen months it was in place.

 

The operating loss for the year was £4.2 million (FY 2019: £2.9 million), whilst cash absorbed by operations and investing activities was £4.1 million (FY 2019: £2.8 million). This directly reflected our increased investment in our operational and technical headcount, tooling, demonstration equipment and costs associated with assembling Extreme E's charging system.

 

Our commercial strategy has begun to be successfully demonstrated by closing the year with an order book of £1.1 million (2019: £ nil); more detail is provided within the Operational Review.

 

People, culture and values

 

Our people have worked tirelessly throughout this financial year to deliver our projects against tight deadlines within the backdrop of social distancing and remote working. The way that our employees have risen to the challenge of maintaining our research, product development, manufacturing and assembly programmes to support our projects despite the challenges posed by the COVID-19 pandemic has made me immensely proud. On behalf of the Board, I would like to thank them all for their professionalism, dedication and understanding during a year like no other.

 

During the year we reviewed our remuneration policy to align with our stakeholder objectives. The first step was a grant of options to existing and new staff to align them with value creation and our principal commercial targets. During the coming year we will roll out further actions to ensure that we attract and retain the right staff and that their objectives and interests are aligned with our stakeholders.

 

Investor communications

 

The COVID-19 pandemic also directly affected how we communicated with our shareholders during the period. Whilst many of our institutional and private investors were present at our Electric Vehicle Charging demonstration in December 2019, social restrictions meant that our annual investor day - planned to coincide with our Annual General Meeting - was postponed. The Board remains committed to regular communication with the market and our investors and is keen to resume its investor day activities in line with Government guidelines.

 

We appointed Iain Thomson as Head of Communication and Stakeholder Management in January 2021 and he will be facilitating a virtual Capital Markets Morning in the Spring to bring us closer to our investors. This event will be one of four key touchpoints across the year where investors can learn more about the company and its strategy, alongside our Annual General Meeting (AGM) and materials relating to our Full Year and Half Year results.

 

The Board is also committed to high standards of public reporting and will put a formal ESG reporting framework in place in 2021 to support investors to measure the positive impact the company has on wider society and in successfully future proofing itself. We believe that the company supports at least nine of the UN's 17 Sustainable Development Goals but also recognise that investors require further detail; a formal update will be provided as part of our Half Year results.

 

Thank you

 

The continued hard work and technical ability of our staff has ultimately set the foundation for what the company will achieve in coming years. My thanks also to our executive team for their leadership, to my colleagues on the Board for their counsel, to our shareholders for their support and commitment, to our customers who recognise the quality of the products we provide, and to all of our other stakeholders who provide input and guidance into our projects.

 

Having served as Chairman for nearly four years it is my intention to retire at the end of the forthcoming Annual General Meeting and I shall therefore not be seeking re-election. It has been a challenging and often exciting period for the company and following the most recent fund raising and the excellent new relationships with Acciona, ABB and Ricardo the company is well placed to accelerate its commercialisation in 2021 and beyond. The Board is progressing a process to identify a successor Chairman and once that person has been appointed I wish them and the company every success in the exciting years ahead.

 

 

John Rennocks

Chairman

26 February 2021

 

Operational review

 

2020 was the year Hydrogen took centre stage. With an unprecedented $300 billion pencilled for investment into new project pipelines and an estimated 18% of the world's energy needs forecast to come from hydrogen over the next few decades[1], this is very much just the start.

For AFC Energy, 2020 was a year in which foundations were laid with first commercial sales, strategic partnerships cemented with global routes to market, high profile technology branding, and unprecedented policy backing across the clean air and sustainable energy agendas.

 

In 2020 alone, 30 of the world's largest economies confirmed Hydrogen Strategies, promoting the sector for the first time into mainstream clean energy portfolio solutions. Such policy support, together with our commercial progress over these past 12 months, cements the company's position as a market leader in the global transition away from diesel generators.

 

The World has changed … and with change comes the opportunity to make things better

 

COVID-19 has placed significant challenges on us all that will see huge changes in both people's day to day social interactions and in the pursuit of national and personal endeavours.

 

Recent studies[2] have however highlighted how the global pandemic has, through implementation of national lockdowns and reduced economic activity, seen significant improvements in air quality, reduced greenhouse gas emissions and improved water quality.

 

As we begin to rebuild the economic drivers of our economies, the policy imperatives being driven by central governments worldwide increasingly reflect the principal of "building back better". A key element of this is a growing recognition of the role Hydrogen is and will continue to play in supporting society to build back in a more sustainable and environmental conscious manner.

 

For AFC Energy, this reality is reflected in the need to reduce society's reliance on fossil fuels and in particular, diesel fuelled power generation. Industries that currently rely on diesel generators all have the potential to benefit from the unique selling points of our proprietary alkaline fuel cell system technology. For over 200 million viewers who will be watching the inaugural Extreme E season powered by our zero-emission technology, AFC Energy will be at the heart of this global transition away from diesel.

 

Today, AFC Energy is engaging with several of the world's leading constructors, diesel generator distributors and global electrification providers in showcasing the strong environmental credentials our fuel cell technology can play in aiding the world's search for Net Zero. Our pipeline of project opportunities has, in response to these environmental circumstances, continued to grow during the course of the 2020 and 2021 lockdowns and we are excited to start converting these opportunities into long term annuity revenue streams.

 

With hundreds of billions of dollars now committed to making the Hydrogen sector a reality, and a relatively small number of core commercial and near commercial technology providers in place today to make this happen, the opportunity for AFC Energy has never been more compelling.

 

First Commercial Orders and Pipeline Growth 

 

2020 saw the conclusion of AFC Energy's first commercial contracts with an order book of £1.1m for delivery during 2021. Our revenue pipeline and partnerships however continue to strengthen alongside the commitment of constructors, power generators and Governments to pursue zero carbon commitments.

Our business model of working through global partners such as ABB continues to validate the merit of our focused go to market strategy.

 

Extreme E was a high profile first contract for the Company which not only delivers revenue, but also tremendous global marketing opportunities. The series will showcase the modular system's flexibility in operating in some of the harshest environmental conditions on Earth, from desert to glacier, and provide a real life, real time demonstration of our system's operability to partners and customers. 

 

To a large degree, our pipeline is strongly supported by Government policy and regulations. These are mandating, at an accelerating rate, a reduction in diesel combustion engines in transport systems, the removal of many of the benefits available to offgrid power generation (such as the UK's subsidy on red diesel ending for the Construction sector from 2022) and enforcing new low emissions standards on stationary power generators. All of these factors are now forcing industry to reconsider the drivers of technology choice in the alternative adoption of legacy diesel generators. This, supported by our low capital cost targets and the ability of our systems to accept low grade hydrogen fuel, enables the Company to position itself in a market which reflects premium priced power, and does not require short term Government subsidy in order to be successful.

 

First Global Distribution Channel

 

Significant effort was also made during the year in promoting and demonstrating our technology both at home and abroad.

 

This began with the Dunsfold to Dundee roadshow in February that physically demonstrated the capabilities of our new EV charger unit and acted as a catalyst for further press coverage and interest in our products.

 

This roadshow culminated in both our agreement with Extreme E and the announcement after year end of our global partnership with world leaders in electrification, ABB. This partnership not only gives ABB access to AFC Energy's leading fuel cell technologies for the rapid charging of electric vehicles, it also provides AFC Energy with access to a global distribution network which has already sold rapid EV charging equipment in over 80 countries.

 

Work has already begun with ABB to integrate their chargepoints with our fuel cells to provide an off-grid solution where the grid is constrained (or absent), with the integrated product launch targeted for later this year. Importantly, we are already in discussions with several of ABB's customers who have expressed interest in the system in locations where large power demand exists, such as high-volume logistics hubs, but where adequate grid connectivity does not.

 

To put the importance of this agreement into context, our commercial team can now access a global market of some 1.2 billion existing vehicles[3], compared with a domestic market of just 38.7 million vehicles[4].

 

This model of working through global distributors can be evidenced across all of AFC Energy's key target markets and we hope to be making further announcements in this regard later in the year.

 

New Partnerships and Collaborations

 

To accelerate our growth and extend our commercial footprint across the world, we have also begun to enter into a series of partnerships and collaborations with key global companies and we view this as a principal part of our commercial strategy moving forward in order to generate a larger volume of sales.

 

In June, we announced a partnership with Acciona SA in support of their stated intention to decarbonise their portfolio of global construction sites. Our programme of work with Acciona this year will explore logistics chains, fuelling strategy (with ammonia), regulatory compliance and the cost effectiveness of our system compared to diesel fuel in off-grid construction applications.

Partnerships such as that announced with Acciona are being developed across several constructors and diesel genset distributors and create large opportunities for early deployment of H-Power systems in markets driven by sustainability agendas.

After period end for example, we also entered into a collaboration agreement with Ricardo plc for both companies to jointly explore and engineer innovative, zero greenhouse emission products with a focus on transportation and stationary power generation, thereby taking advantage of clear growth in industrial customer demand. The partnership is closely considering the benefits achieved using low cost, readily available, and high energy dense green ammonia fuel (rather than hydrogen gas) as a fuel of choice in off-grid or remote power needs, including international shipping and distributed power generation.

 

Manufacturing scale up

 

Our 2020 contracts and the strength of our potential order pipeline placed a spotlight on our dependence upon the small workforce we have at Dunsfold. We subsequently took three actions to ensure that our manufacturing capability can meet current and future orders.

 

Our partnership with BK Gulf, announced after period end, supports the immediate scale up of manufacturing capacity for delivery of our power systems through the delivery of the Company's containerised fuel cell balance of plant. BK Gulf has the existing capacity to deliver several hundred fitted out containerised modules per annum to address future customer demand, with the first fabricated units expected this year. In parallel with this work, BK Gulf has also commenced a detailed value engineering process to further optimise our system layout and drive cost reduction. Our partnership with De Nora also remains strong following the extension of our Joint Development Agreement, with their electrodes continuing to be used in all of our projects.

 

Our successful £31.6 million fundraise in July also supported two key internal actions. To further scale up fuel cell system assembly and commissioning to satisfy existing and future orders, we announced in November that we'd taken a lease over a 30,000 sq. ft unit at Dunsfold Park to serve as our first large scale H-PowerTM assembly and commissioning facility. This provides the space for the assembly of fuel cell systems of any scale before commissioning and despatch to customers.

 

In addition, the fundraise provided the financial headroom to recruit new manufacturing, engineering and commercial staff in support of the deployment of our systems into the Company's key target markets. We will be announcing a further strengthening of our executive team shortly and it's a tribute to our progress that we can now attract such talent to our business.

 

Product and technology development

 

Our technology platform is at the heart of our value proposition, and with a three pillar approach to technology development, we are confident our market leading position in alkaline fuel cell systems continues to be strengthened.

 

The first of these pillars represents the HydroX-Cell(L) fuel cell system which is currently set for deployment in all of our current and near term pipeline of projects. The focus here continues to be predicated on lowering of cost and enhancement of performance. Our partnership with Industrie De Nora continues to pay dividends as they further invest in our L Series electrode technology through Joint Development Agreement, with BK Gulf now supporting the value engineering of modular, containerised systems.

 

The second pillar represents to HydroX-Cell(S) fuel cell system which continues to be scaled up towards a full commercial prototype system expected for delivery later this year. The S Series system continues to demonstrate market leading power densities for alkaline fuel cell systems designed to compete head on with existing Proton Exchange Membrane (PEM) based technologies in mobile applications where power density and footprint are key. The key differentiator is the alkaline system's ability to accept lower grade, and therefore lower cost Hydrogen (including that sourced from Ammonia) with a far lower loading of high cost metals within its electro-chemistry. We continue to believe the S Series fuel cell will be a game changer for the hydrogen sector.

 

Finally, the third pillar represents the AlkaMem® anion exchange membrane, used within the S Series fuel cell system, but which can equally be applied in other non fuel cell applications such as alkaline water electrolysis. AlkaMem® has now been dispatched to several leading industrial and research entities and continues to highlight the potential for our technology in these markets. 2020 presented certain challenges across the AlkaMem® supply chain however we are now through this and continue to prepare the membrane for third party users in 2021.

 

Fuel

The unique selling point of our equipment to accept low grade, cheaper hydrogen sources - especially ammonia, which has been confirmed as our strongest competitive advantage by our customers. Adoption of ammonia as a preferred vector for the carriage of Hydrogen is gaining momentum, particularly in heavy mobile applications such as shipping. We are continuing to work closely with the ammonia industry, including joining the Ammonia Energy Association as Gold Members in 2020.

 

Outlook

 

Our outlook for the coming year is one of confidence, with both Governmental policies and industry sentiment driving sustainable change in our key target markets. The company's strong balance sheet position enables us to invest in our people, products and technology and we therefore expect cash burn to modestly increase in the coming year - partly offset by an increase in customer revenues - to accelerate our commercial growth.

 

With regulations pertaining to diesel generation continuing to tighten, environmental and societal change agendas becoming more prevalent, the rate of Electric Vehicle deployment and their required rate of charge increasing, and the cost of Hydrogen continuing to fall whilst diesel does the opposite, this will drive additional interest and ultimately drive sales of our products in our target markets.

 

Beyond this clear opportunity, we have also begun to put in place the required distribution channels, manufacturing and staffing to turn these opportunities into significant revenue. Leveraging the value of our international partnerships and collaborations remains central to our approach in 2021.

 

Whilst the COVID-19 pandemic has had an obvious impact on all businesses, we demonstrated in 2020 that we have been able to work safely and efficiently in meeting the needs of our customers whilst continuing to develop our product base. I expect us to maintain this momentum throughout 2021.

 

This transformational year has been the result of innovative, passionate and committed effort by a team with the single-minded desire to bring "emissions-free solutions to the world's energy challenges". I wish to take this opportunity to thank our staff, partners and supply chain for their tremendous efforts and I look forward to even greater things in the future.

 

Adam Bond

Chief Executive Officer

26 February 2021

 

 

Statement of Comprehensive Income

FOR THE YEAR ENDED 31 OCTOBER 2020

 

 

 

 

 

 

 

 

Year ended

Year ended

 

 

 

 

 

 

31 October 2020

31 October 2019

 

 

 

 

 

Note

£

£

Revenue from customer contracts

 

 

 

 

 

-

-

Cost of sales

 

 

 

 

 

-

(26)

Gross loss

 

 

 

 

 

-

(26)

 

 

 

 

 

 

 

 

Other income

 

 

 

 

 

32,892

39,729

Administrative expenses

 

 

 

 

 

(4,639,104)

(3,606,266)

Operating loss

 

 

 

 

5

(4,606,212)

(3,566,563)

 

 

 

 

 

 

 

 

Finance cost

 

 

 

 

8

(178,407)

(52,805)

Loss before tax

 

 

 

 

 

(4,784,619)

(3,619,368)

Taxation

 

 

 

 

9

559,627

768,528

Loss for the financial year and total comprehensive loss attributable to owners of the Company

 

 

 

 

 

 

(4,224,992)

 

(2,850,840)

 

 

 

 

 

 

 

 

Basic loss per share

 

 

 

 

10

(0.80)p

(0.68)p

Diluted loss per share

 

 

 

 

10

(0.80)p

(0.68)p

 

All amounts relate to continuing operations.

 

The notes form part of these financial statements.

 

 

 

 

 

Statement of Financial Position

AS AT 31 OCTOBER 2020

 

 

 

 

 

 

31 October 2020

31 October 2019

 

 

 

 

Note

£

£

 

Assets

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

 

Intangible assets

 

 

11

769,269

606,041

 

Right of use assets

 

 

12

247,505

361,738

 

Tangible fixed assets

 

 

13

940218

396,935

 

 

 

 

 

1,956,992

1,364,714

 

Current assets

 

 

 

 

 

 

Inventory

 

 

15

249,370

95,423

 

Receivables

 

 

16

1,043,880

1,151,998

 

Cash and cash equivalents

 

 

17

31,301,467

1,327,935

 

Restricted cash

 

 

17

270,027

259,072

 

 

 

 

 

32,864,744

2,834,428

 

 

 

 

 

 

 

 

Total assets

 

 

 

34,821,736

4,199,142

 

 

 

 

 

 

 

 

Capital and reserves attributable to owners of the Company

 

 

 

 

 

 

Share capital

 

 

18

676,006

447,988

 

Share premium

 

 

18

81,417,845

47,389,424

 

Other reserve

 

 

 

1,512,974

2,204,774

 

Retained deficit

 

 

 

(50,582,856)

(47,185,257)

 

Total equity attributable to Shareholders

 

 

 

33,023,969

2,856,929

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Payables

 

 

20

1,236,796

667,811

 

Lease liabilities

 

 

21

113,431

113,431

 

 

 

 

 

1,350,227

781,242

 

Non-current liabilities

 

 

 

 

 

 

Lease liabilities

 

 

21

146,368

259,799

 

Provisions

 

 

22

301,172

301,172

 

 

 

 

 

447,540

560,971

 

Total liabilities

 

 

 

1,797,767

1,342,213

 

 

 

 

 

 

 

 

Total equity and liabilities

 

 

 

34,821,736

4,199,142

 

 

The notes form part of these financial statements.

 

These financial statements were approved and authorised for issue by the Board on 26 February 2021.

 

 

ADAM BOND GRAEME LEWIS

Chief Executive Officer Chief Financial Officer

 

AFC Energy plc

Registered number: 05668788 

 

 

Statement of Changes in Equity

FOR THE YEAR ENDED 31 OCTOBER 2020

 

 

 

 

 

Share

Share

Other

Retained

Total

 

 

 

Capital

Premium

Reserve

Deficit

Equity

 

 

Note

£

£

£

£

£

31 October 2018

 

 

391,698

45,506,524

2,908,021

(44,487,129)

4,319,114

Adjustment from the adoption of IFRS 16

 

 

-

-

-

(6,794)

(6,794)

Adjusted balance at 31 October 2018

 

 

391,698

45,506,524

2,908,021

(44,493,923)

4,312,320

Comprehensive loss for the year

 

 

 

-

 

-

 

-

 

(2,850,840)

 

(2,850,840)

Issue of equity shares

 

 

56,290

1,882,900

-

-

1,939,190

Equity-settled share-based payments

 

 

 

-

 

-

 

(703,247)

 

159,506

 

(543,741)

Transactions with owners

 

 

56,290

1,882,900

(703,247)

159,506

1,395,449

31 October 2019

 

 

447,988

47,389,424

2,204,774

(47,185,257)

2,856,929

 

 

 

 

 

 

 

 

Comprehensive loss for the year

 

 

-

-

-

(4,224,992)

(4,224,992)

Issue of equity shares

 

18

226,873

33,798,289

-

-

34,025,162

Exercise of share options

 

 

1,145

230,132

 

 

231,277

Equity-settled share-based payments

 

 

19

 

-

 

-

 

(691,800)

 

827,393

 

135,593

Transactions with owners

 

 

228,018

34,028,421

(691,800)

827,393

34,392,032

31 October 2020

 

 

676,006

81,417,845

1,512,974

(50,582,856)

33,023,969

 

Share capital is the amount subscribed for shares at nominal value.

 

Share premium represents the excess of the amount subscribed for share capital over the nominal value of these shares net of share issue expenses.

 

Other reserve represents the charge to equity in respect of unexercised equity-settled share-based payments.

 

Retained deficit represents the cumulative loss of the Company attributable to equity Shareholders.

 

The notes form part of these financial statements.

 

 

 

Cash Flow Statement

FOR THE YEAR ENDED 31 OCTOBER 2020

 

 

 

 

 

 

 

 

31 October 2020

31 October 2019

 

 

 

 

 

Note

£

£

Cash flows from operating activities

 

 

 

 

 

 

 

Loss before tax for the year

 

 

 

 

 

(4,784,619)

(3,619,368)

Adjustments for:

 

 

 

 

 

 

 

 Amortisation of intangible assets

Depreciation of right of use asset

Depreciation of property and equipment

Depreciation of decommissioning asset

 

 

 

 

11

12

13

13

108,014

114,233

143,758

31,365

35,388

114,233

88,950

31,364

 Equity-settled share-based payment expenses

 

 

 

 

19

135,593

(543,741)

 Interest received

 

 

 

 

8

(6,168)

(4,173)

Gain on disposal of investment and allied agreements

 

 

 

 

14

(80,000)

(20,000)

Cash flows from operating activities before changes in working capital and provisions

 

 

 

 

 

(4,337,824)

(3,917,347)

R&D tax credits received

 

 

 

 

 

644,523

1,299,360

(Increase)/Decrease in restricted cash

 

 

 

 

 

(10,955)

6,702

(Increase)/Decrease in inventory

 

 

 

 

 

(153,947)

68,297

Decrease in receivables

 

 

 

 

 

23,222

76,910

Increase in payables

 

 

 

 

 

568,985

26,264

Cash absorbed by operating activities

 

 

 

 

 

(3,265,996)

(2,439,814)

 

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

 

 

Purchase of plant and equipment

 

 

 

 

13

(718,406)

(224,253)

Additions to intangible assets

 

 

 

 

11

(171,242)

(198,743)

Interest received

 

 

 

 

8

6,168

4,173

Proceeds from disposal of investment and allied agreements

 

 

 

 

14

80,000

20,000

Net cash absorbed by investing activities

 

 

 

 

 

(803,480)

(398,823)

 

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

 

Proceeds from the issue of share capital

 

 

 

 

 

35,558,667

1,888,940

Costs of issue of share capital

 

 

 

 

 

(1,633,505)

(149,750)

Proceeds from the exercise of options

 

 

 

 

 

231,277

-

Lease payments

 

 

 

 

 

(113,431)

(124,686)

Net cash from financing activities

 

 

 

 

 

34,043,008

1,614,504

 

 

 

 

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

 

 

 

 

 

29,973,532

(1,224,133)

Cash and cash equivalents at start of year

 

 

 

 

 

1,327,935

2,552,068

Cash and cash equivalents at end of year

 

 

 

 

17

31,301,467

1,327,935

 

The notes form part of these financial statements. 

 

 

Notes Forming Part of the Financial Statements

 

 

1. CORPORATE INFORMATION

AFC Energy plc ("the Company") is a public limited company incorporated in England & Wales and quoted on the Alternative Investment Market of the London Stock Exchange.

 

The address of its registered office is Unit 71.4 Dunsfold Park, Stovolds Hill, Cranleigh, Surrey GU6 8TB.

 

2. BASIS OF PREPARATION AND ACCOUNTING POLICIES

The financial statements of AFC Energy plc have been prepared in accordance with International Financial Reporting Standards ("IFRSs"), International Accounting Standards ("IASs") and International Financial Reporting Interpretations Committee ("IFRIC") interpretations (collectively "IFRSs") as adopted for use in the European Union and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS.

 

These results are audited, however the financial information does not constitute statutory accounts as defined under section 434 of the Companies Act 2006. The financial information for the year ended 31 October has been derived from the Company's statutory accounts for that year. The auditors' report on the statutory accounts for the year ended 31 October 2020 was unqualified and did not contain statements under section 498 of the Companies Act 2006.

 

The accounting policies used in completing this financial information have been consistently applied in all periods shown. These accounting policies are detailed in the Company's financial statements for the year ended 31 October 2020 which can be found on the Company's website.

 

The financial statements have been prepared on a going concern basis notwithstanding the trading losses being carried forward and the expectation that the trading losses will continue for the near future as the Company transitions from research and development to commercial operations.

 

The Company currently consumes cash resources and will continue to do so until sales revenues are sufficiently high to generate net cash inflows. Management have prepared and reviewed five-year financial projections aligned with ongoing technological, operational and commercial strategies. During the initial period of commercialisation there will be negative cash flows the size of which will be dependent upon the speed at which revenue grows. On 31 October 2020 unrestricted cash resources were £ 31.3 million. The Directors have reasonable expectation that sufficient funding exists to meet payment obligations as and when they fall due. The directors' having taken into account current cash resources, identified risks including the impact of Covid 19 and financial forecasts the Company has adequate resources to continue in operational existence for the foreseeable future (being a period of at least twelve months from the date of this report). Thus, the Directors believe that it is reasonable to continue to adopt the going concern basis in preparing the annual report and financial statements.

 

The accounting policies set out below have, unless otherwise stated, been applied consistently in these financial statements.

 

Judgements made by the Directors in the application of these accounting policies that have significant effect on the financial statements and estimates with a significant risk of material adjustment in the next year are discussed in note 3.

 

a. Standards, Amendments and Interpretations to Published Standards not yet Effective.

At the date of authorisation of these financial statements, all the IASB and IFRIC standards and interpretations, which are effective for annual accounting periods beginning on or after the stated effective date have been adopted.

 

b. Capital Policy

The Company manages its equity as capital. Equity comprises the items detailed within the principal accounting policy for equity and financial details can be found in the statement of financial position. The Company adheres to the capital maintenance requirements as set out in the Companies Act.

 

c. Revenue recognition

To determine whether to recognise revenue, a 5-step process is followed:

· Identifying the contract with a customer

· Identifying the performance obligations

· Determining the transaction price

· Allocating the transaction price to the performance obligations

· Recognising revenue as the performance obligations are satisfied.

 

Revenue is generated from complex contracts covering the

· Sale of goods and parts,

· Sale of services and maintenance, and

· Lease contracts.

and may be either a single or multiple contracts. Multiple contracts are accounted for as a single contract where one or more of the following criteria are met

· The contracts were negotiated as a single commercial package,

· Consideration of one contract depends upon the other contract, and

· Some or all of the goods and services comprise a single performance obligation.

Performance obligations of the contracts are analysed between either physical goods and services delivered or service level agreements. The transaction price of the performance obligations are based upon the contract terms taking in to account both cash and non-cash consideration. Non- cash consideration is valued at fair value taking in to consideration contract terms and known arms length pricing where available.

 

Revenue is recognised either at a point in time or over time, as the performance obligations are satisfied by transferring the promised goods or services to its customers. Contract liabilities are recognised for consideration received in respect of unsatisfied performance obligation and reports these amounts as other Contract and other liabilities in the statement of financial position. Similarly, if a performance obligation is satisfied before it receives the consideration, a contract asset or a receivable is recognised in the statement of financial position, depending on whether something other than the passage of time is required before the consideration is due.

 

Sale (standard products) contracts - Revenue from standard products will be recognised at a point of time only when the performance obligation has been fulfilled and ownership of the goods has transferred, which is typically at site or factory acceptance, which is the official handover of control of the goods to the customer.

· During the product build, deposits and progress payments will be reflected in the balance sheet as deferred income.

· Costs incurred on projects to date will not be included in the statement of comprehensive income but will be accumulated on the balance sheet as work in progress (as they are considered recoverable) and transferred to cost of sales once the revenue applicable to those costs can be recognised in the accounts. Should costs exceed anticipated revenues, a provision will be recognised and the surplus costs expensed with immediate effect.

 

Sale (customised products) contracts - Revenues for customised contracts will be recognised over time according to how much of the performance obligation has been satisfied. This is measured using the input method, comparing the extent of inputs towards satisfying the performance obligation with the expected total inputs required. Any changes in expectation are reflected in the total inputs figure as they become known. The progress percentage obtained is then applied to the revenue associated with that performance obligation.

 

Lease and long-term service contracts - Revenue is recognised over time based on outputs provided to the customer, because this is the most accurate measurement of the satisfaction of the performance obligation. Revenue can comprise a fixed rental charge and a variable charge related to the usage of assets or other services (including pass-through fuel).

 

d. Other Income

Other income represents sales by the Company of waste materials.

 

e. Development Costs

Identifiable non-recurring engineering and design costs and other prototype costs incurred to develop a technically and commercially feasible product are capitalised.

 

f. Foreign Currency

The financial statements of the Company are presented in the currency of the primary economic environment in which it operates (the functional currency) which is pounds sterling. In accordance with IAS 21, transactions entered into by the Company in a currency other than the functional currency are recorded at the rates ruling when the transactions occur. At each Statement of Financial Position date, monetary items denominated in foreign currencies are retranslated at the rates prevailing at the Statement of Financial Position date.

 

g. Inventory

Inventory is recorded at the lower of cost and net realisable value.

 

h. Other Receivables

These assets are initially recognised at fair value and are subsequently measured at amortised cost less any provision for impairment.

 

i. Tangible fixed assets

Property and equipment are stated at cost less any subsequent accumulated depreciation and impairment losses.

 

Right-of-use assets are measured at either:

- Their carrying amount as if IFRS 16 has been applied since commencement, discounted using the lessee's incremental borrowing rate at the date of initial application

- An amount equal to the lease liability, adjusted for any prepaid or accrued lease payments

Where parts of an item of property and equipment have different useful lives, they are accounted for as separate items of property and equipment.

 

Depreciation is charged to the statement of comprehensive income within cost of sales and administrative expenses on a straight-line basis over the estimated useful lives of each part of an item of property, plant and equipment. The estimated useful lives are as follows:

 

• Right of use asset - building life of the lease

• Leasehold improvements 1 to 3 years

• Decommissioning asset life of the lease

• Fixtures, fittings and equipment 1 to 3 years

• Motor vehicles 3 to 4 years

• Demonstration equipment 5 years

• Rental fleet 5 years

Expenses incurred in respect of the maintenance and repair of property and equipment are charged against income when incurred. Refurbishment and improvement expenditure, where the benefit is expected to be long lasting, is capitalised as part of the appropriate asset.

 

The useful economic lives of property, plant and equipment and the carrying value of tangible fixed assets are assessed annually and any impairment is charged to the statement of comprehensive income.

 

j. Intangible Assets

Expenditure in establishing a patent is capitalised and written off over its useful life.

 

Other intangible assets that are acquired by the Company are stated at cost less accumulated amortisation and impairment losses.

 

Amortisation of intangible assets is charged using the straight-line method to administrative expenses over the following period:

 

• Development costs 5 years

• Patents 20 years

 

Useful lives are based on the management's estimates of the period that the assets will generate revenue, which are periodically reviewed for continued appropriateness and any impairment is charged to the statement of comprehensive income.

 

k. Impairment testing of intangible assets and property, plant and equipment

At each statement of financial position date, the carrying amounts of the assets are reviewed to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). In assessing whether an impairment is required, the carrying value of the asset is compared with its recoverable amount. The recoverable amount is the higher of the fair value less costs of disposal (FVLCD) and value in use (VIU).

 

l. Lease liabilities

 

Measurement and recognition of leases as lessee

At lease commencement date, a right of use and lease liability are recognised on the Statement of Financial Position. The right of use asset is measured at cost, which comprises the initial measurement of the lease liability, any initial direct costs incurred, an estimate of costs to dismantle and remove the asset at the end of the lease term and any lease payments made in advance of the lease commencement date.

 

Lease payments included in the measurement of the lease liability are made up of fixed payments (including in substance fixed), variable payments based on an index or rate, amounts expected to be payable under a residual value guarantee and payments arising from options reasonably certain to be exercised.

 

Subsequent to initial measurement, the liability will be reduced for payments made and increased for interest. It is remeasured to reflect any reassessment or modification, or if there are changes in in-substance payments.

 

When the lease liability is remeasured, the corresponding adjustment is reflected in the right of use asset, or profit and loss if the right of use asset is already reduced to zero.

 

Short term leases and low value assets have been accounted for using the practical expedients set out in IFRS 16 and the payments are recognised as an expense in profit or loss on a straight-line basis over the lease term.

 

m. Financial Instruments

Financial instruments are measured on initial recognition at fair value, plus, in the case of financial instruments other than those classified as fair value through profit or loss ("FVPL"), directly attributable transaction costs. Financial instruments are recognized when the Company becomes a party to the contracts that give rise to them and are classified as amortized cost, fair value through profit or loss or fair value through other comprehensive income, as appropriate. The Company considers whether a contract contains an embedded derivative when the entity first becomes a party to it. The embedded derivatives are separated from the host contract if the host contract is not measured at fair value through profit or loss and when the economic characteristics and risks are not closely related to those of the host contract. Reassessment only occurs if there is a change in the terms of the contract that significantly modifies the cash flows that would otherwise be required.

 

In the periods presented the Group does not have any financial assets categorised as FVPL or FVOCI.

 

Financial assets at amortized cost

A financial asset is measured at amortized cost if it is held within a business model whose objective is to hold assets to collect contractual cash flows and its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding, and is not designated as FVPL. Financial assets classified as amortized cost are measured subsequent to initial recognition at amortized cost using the effective interest method. Cash, restricted cash, trade receivables and certain other assets are classified as and measured at amortized cost.

 

Financial liabilities

Financial liabilities are classified as measured at amortized cost or FVTPL. A financial liability is classified as at FVTPL if it is classified as held-for-trading, it is a derivative or it is designated as such on initial recognition. Financial liabilities at FVTPL are measured at fair value and net gains and losses, including any interest expense, are recognized in profit or loss. Other financial liabilities are subsequently measured at amortized cost using the effective interest method. Gains and losses are recognized in net earnings when the liabilities are derecognized as well as through the amortization process. Borrowing liabilities are classified as current liabilities unless the Company has an unconditional right to defer settlement of the liability for at least 12 months after the statement of financial position date. Accounts payable and accrued liabilities and finance leases are classified as and measured at amortized cost.

 

Impairment of financial assets

A loss allowance for expected credit losses is recognized in OCI for financial assets measured at amortized cost. At each balance sheet date, on a forward-looking basis, the Company assesses the expected credit losses associated with its financial assets carried at amortized cost. The impairment methodology applied depends on whether there has been a significant increase in credit risk. The expected credit losses are required to be measured through a loss allowance at an amount equal to the 12-month expected credit losses (expected credit losses that result from those default events on the financial instrument that are possible within 12 months after the reporting date) or full lifetime expected credit losses (expected credit losses that result from all possible default events over the life of the financial instrument). A loss allowance for full lifetime expected credit losses is required for a financial instrument if the credit risk of that financial instrument has increased significantly since initial recognition.

 

Derecognition of financial assets and liabilities

A financial asset is derecognized when either the rights to receive cash flows from the asset have expired or the Company has transferred its rights to receive cash flows from the asset or has assumed an obligation to pay the received cash flows in full without material delay to a third party. If neither the rights to receive cash flows from the asset have expired nor the Company has transferred its rights to receive cash flows from the asset, the Company will assess whether it has relinquished control of the asset or not. If the Company does not control the asset then derecognition is appropriate. A financial liability is derecognized when the associated obligation is discharged or cancelled or expires. When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying amounts is recognized in net earnings.

 

n. Share-Based Payment Transactions

 

The fair value of options and warrants granted is recognised as an employee expense with a corresponding increase in Other Reserve. The fair value of the expense is estimated at grant date using either the Black-Scholes option valuation model considering the terms and conditions upon which they were granted or a Log normal Monte Carlo stochastic model for market conditions. The expense accrues from the grant date until the options and warrants have unconditionally vested. Where vesting is dependent upon market or non-market performance criteria the vesting period is estimated at the grant date and, in the case of non-market performance criteria, is revised annually. When an option or warrant is exercised the balance is transferred to share capital with excess value going to the premium account whereas those that lapse are transferred to retained earnings. Where options or warrants are amended by the introduction of new schemes and the absorption of earlier schemes by agreement between the Company and the beneficiary the net difference in valuation is charged to earnings in the appropriate period.

 

o. Provisions

Provisions are recognised when the Company has a present obligation as a result of a past event and it is probable that the Company will be required to settle the obligation. Provisions are measured at the present value of management's best estimate of the expenditure required to settle the present obligation at the Statement of Financial Position date and are discounted to present value where the effect is material.

 

p. Taxation

Tax on the profit or loss for the year comprises current and deferred tax. Tax is recognised in the statement of comprehensive income except to the extent that it relates to items recognised directly in equity, in which case it is recognised in equity.

 

Current tax is the expected tax payable or recoverable on the taxable income for the year, using tax rates enacted or substantively enacted at the Statement of Financial Position date together with any adjustment to tax payable in respect of previous years.

 

Deferred tax assets are not recognised due to the uncertainty of their recovery.

 

q. R&D Tax Credits

The Company's research and development activities allow it to claim R&D tax credits from HMRC in respect of qualifying expenditure; these credits are reflected in the statement of comprehensive income in the taxation line depending on the nature of the credit.

 

r. Pension Contributions

The Company operates a defined contribution pension scheme which is open to all employees and makes monthly employer contributions to the scheme in respect of employees who join the scheme. These employer contributions are currently capped at 4% of the employee's salary and are reflected in the statement of comprehensive income in the period for which they are made.

 

3. CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION AND UNCERTAINTY

In the preparation of the financial statements, management makes certain judgements and estimates that impact the financial statements. While these judgements are continually reviewed, the facts and circumstances underlying these judgements may change, resulting in a change to the estimates that could impact the results of the Company. In particular:

 

Significant management judgements:

 

The following are the judgements made by management in applying the accounting policies of the Company that have the most significant effect on the financial statements:

 

Customer contracts and revenue recognition

Customer contracts typically include the provision of

· engineering, manufacturing, installation, commissioning, and maintenance of standard and customised alkaline fuel cell systems and integrated auxiliary equipment, and

· access to or sale of technology.

These performance obligations are provided for as either

· Lease contract, or

· Sale contract

In accordance with IFRS 16 management defines a lease as "A contract, or part of a contract, that conveys the right to use an identified asset for a period of time in exchange for consideration". For such a contract to exist the user of the asset needs to have the right to:

· Obtain substantially all the economic benefits from the use of the asset.

· The right to direct the use of the asset.

All other contracts, or part of a contract, are treated as sale contracts.

 

Sales contracts are analysed in accordance with the 5-step principle laid out by IFRS 15 and management distinguish between

 

· Standard products,

· Customised products, and

· Services.

 

The distinction between standard and customised products arises from whether the products and auxiliary components up to the point of customer handover have alternative uses. Customised contracts by their nature do not create an asset with an alternative use as they are customised to the customers' requirements which cannot be easily converted for use on another project.

 

Customer agreements can be complex, involve multiple legal documents and have a duration covering multiple accounting periods including different performance obligations and payment terms designed to manage cash flow rather than the underlying arm's length transaction price. Management use judgement to identify the specific performance obligations and allocate the total expected revenue to the identified performance obligations. These judgements are made based on the interpretation of key clauses and conditions within each customer contract. Revenue is recognised when the performance obligation has been met. For standard products the performance obligations are assumed to be met when the customer takes delivery usually evidenced by either a factory or site acceptance test depending upon the agreed delivery terms. For customised products management consider that revenue can be recognised over time due to their status as custom builds. In accounting for their revenue under this method, management must take a view of the total costs required for each performance obligation together with the actual spend already recognised in cost of sales to be able to recognise an equivalent proportion of the revenue for that performance obligation. As this relates to expense not yet incurred, the projections are largely based on budgeted costs or quotes for costs. Management view this as a much more reliable measure of progress towards completion of the performance obligation than the output method as, despite contracting with milestone payments, these are not reliable measures of progress or value to the customer but instead have been designed to aid cash flow.

 

Project reviews covering cost forecasts and technical progress are monitored periodically to ensure that any potential losses are recognised immediately in the accounts in accordance with IAS 37.

 

Income Taxes and Withholding Taxes

The Company believes that its receivables for tax recoverable are adequate for all open audit years based on its assessment of many factors, including experience and interpretations of tax law. This assessment relies on estimates and assumptions and may involve a series of complex judgements about future events. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences will impact income tax expense in the period in which such determination is made.

 

Capitalisation of Development Expenditure

The Company uses the criteria of IAS 38 to determine whether development expenditure should be capitalised. Management identify separately non-recurring engineering, design costs and prototype costs incurred to develop demonstration units used in marketing activities and customer trials. Management believe that the Development Expenditure will continue to support marketing and customer trials for the foreseeable future. This assessment relies upon judgements about future customer behaviour taking in to account the feedback received from prospective customers and future product improvements which influence the economic useful life and residual value of said assets. To the extent that customer demand or competing products enter the market the economic useful life and residual value of the Development Expenditure may change which will impact depreciation and amortisation expenses for the period in which such determination is made.

 

Estimation uncertainty:

 

Information about estimates and assumptions that may have the most significant effect on recognition and measurement on assets, liabilities and expenses is provided below.

 

Share-Based Payments

Certain employees (including Directors and senior Executives) of the Company receive remuneration in the form of share-based payment transactions, whereby employees render services as consideration for equity instruments ("equity-settled transactions").

 

The fair value is determined using either the Black-Scholes valuation model or a Log-normal Monte Carlo stochastic model for market conditions. Both are appropriate considering the effects of the vesting conditions, expected exercise period and the dividend policy of the Company.

 

The cost of equity-settled transactions is accrued, together with a corresponding increase in equity over the period the directors expect the performance criteria will be fulfilled. For market performance criteria this estimate is made at the time of grant considering historic share price performance and volatility. For non-market performance criteria an estimate is made at the time of grant and reviewed annually thereafter considering progress on the operational objectives set, plans and budgets.

 

Expected volatility has been based on the 3.5-year historical volatility of share price. Vesting requirements are three years for the exercise of warrants and options, except for 500,000 options granted which vest in two years. Certain options granted to Directors are also subject to performance conditions described in note 18.

 

Decommissioning Provision

The Company has set-up a decommissioning provision for the removal of the plant and equipment installed at the Stade site in Germany, the cost of which is based on estimates. Various scenarios have been considered which estimate the range of costs to be from £ 35,000 to £ 301,000 dependent upon agreements reached with lessor.

 

4. SEGMENTAL ANALYSIS

Operating segments are determined by the chief operating decision maker based on information used to allocate the Company's resources. The information as presented to internal management is consistent with the statement of comprehensive income. It has been determined that there is one operating segment, the development of fuel cells. In the year to 31 October 2020, the Company operated mainly in the United Kingdom and in Germany. All non-current assets are located in the United Kingdom.

 

5. OPERATING LOSS

This has been stated after:

 

 

 

 

 

 

 

Year ended

Year ended

 

 

 

 

 

 

31 October 2020

31 October 2019

 

 

 

 

 

 

£

£

Amortisation/Impairment of intangible assets

 

 

 

 

 

108,014

35,338

Depreciation of right of use asset

 

 

 

 

 

114,233

114,233

Depreciation of property and equipment

 

 

 

 

 

143,758

88,950

Depreciation of decommissioning asset

 

 

 

 

 

31,365

31,364

R&D expenditure

 

 

 

 

 

1,553,519

1,808,080

Equity-settled share-based payment expense

 

 

 

 

 

135,593

(543,741)

Foreign exchange differences

 

 

 

 

 

(23,046)

27,068

Auditor's remuneration - audit

 

 

 

 

 

49,172

56,500

Auditor's remuneration - corporation tax services

 

 

 

 

 

7,450

6,700

Auditor's remuneration - R&D tax credit services

 

 

 

 

 

25,000

25,000

 

6. STAFF NUMBERS AND COSTS, INCLUDING DIRECTORS

The average numbers of employees in the year were

 

 

 

 

 

 

 

Year ended

Year ended

 

 

 

 

 

 

31 October 2020

31 October 2019

 

 

 

 

 

 

Number

Number

Support, operations and technical

 

 

 

 

 

24

20

Administration

 

 

 

 

 

6

6

 

 

 

 

 

 

30

26

 

The aggregate payroll costs for these persons were:

 

 

 

 

 

 

 

£

£

Wages and salaries (including Directors' emoluments)

 

 

 

 

 

1,901,966

1,628,330

Social security

 

 

 

 

 

192,706

183,353

Employer's pension contributions

 

 

 

 

 

72,084

40,606

Equity-settled share-based payment expense

 

 

 

 

 

135,593

(543,741)

 

 

 

 

 

 

2,302,349

1,308,548

 

 

 

 

 

7. DIRECTORS' REMUNERATION

 

 

 

 

 

 

Year ended

Year ended

 

 

 

 

 

 

31 October 2020

31 October 2019

 

 

 

 

 

 

£

£

Wages and salaries

 

 

 

 

 

963,559

645,876

Social security

 

 

 

 

 

104,667

81,177

Equity-settled share-based payment expense

 

 

 

 

 

89,943

19,663

Other compensation

 

 

 

 

 

67,717

61,066

Company pension contributions

 

 

 

 

 

36,433

11,938

 

 

 

 

 

 

1,262,319

819,720

 

 

 

 

 

 

 

 

 

The remuneration, details of share options and interests in the Company's shares of each Director are shown in the Directors' Report.

 

8. NET FINANCe COST

 

 

 

 

 

 

Year ended

Year ended

 

 

 

 

 

 

31 October 2020

 

31 October 2019

 

 

 

 

 

 

£

£

Lease Interest

 

 

 

 

 

12,072

16,955

Bank charges

 

 

 

 

 

172,503

40,023

Finance cost

 

 

 

 

 

184,575

56,978

Bank interest receivable

 

 

 

 

 

(6,168)

(4,173)

 

 

 

 

 

 

178,407

52,805

 

9. TAXATION

 

 

 

 

 

 

Year ended

Year ended

 

 

 

 

 

 

31 October 2020

31 October 2019

Recognised in the statement of comprehensive income

 

 

 

 

 

£

£

R&D tax credit - current year

 

 

 

 

 

(518,099)

(602,995)

R&D tax credit - prior year

 

 

 

 

 

(41,528)

(165,533)

Total tax credit

 

 

 

 

 

(559,627)

(768,528)

 

 

 

 

 

 

 

 

Reconciliation of effective tax rates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss before tax

 

 

 

 

 

(4,775,519)

(3,619,368)

Tax using the domestic rate of corporation tax of 19% (2019: 19%)

 

 

 

 

 

(907,349)

(687,680)

 

 

 

 

 

 

 

 

Effect of:

 

 

 

 

 

 

 

R&D tax credit - prior year

 

 

 

 

 

(41,528)

(165,533)

Timing differences not deductible for tax purposes

 

 

 

 

 

29,792

(14,929)

R&D allowance

 

 

 

 

 

(383,719)

(446,596)

Tax credit on losses surrendered

 

 

 

 

 

(518,099)

(602,995)

Depreciation in excess of capital allowances

 

 

 

 

 

27,314

16,957

Losses surrendered for research and development

 

 

 

 

 

678,888

790,131

Unutilised losses carried forward

 

 

 

 

 

555,074

342,117

Total tax credit

 

 

 

 

 

(559,627)

(768,528)

 

Potential deferred tax assets have not been recognised but are set out below

 

 

 

 

 

 

 

Year ended

Year ended

 

 

 

 

 

 

31 October 2020

 

31 October 2019

 

 

 

 

 

 

£000s

£000s

Share based payments

 

 

 

 

 

30

-

Losses carried forward

 

 

 

 

 

5,879

4,747

Potential deferred tax asset

 

 

 

 

 

5,909

4,747

 

The deferred tax assets have not been recognised as the Directors consider that it is unlikely that they will be realised in the foreseeable future. The potential deferred tax asset are calculated using the estimated UK tax rate of 19% (2019: 17%).

 

 

 

10. LOSS PER SHARE

The calculation of the basic loss per share is based upon the net loss after tax attributable to ordinary Shareholders of £ 4,224,992 (2019: loss of £2,850,840) and a weighted average number of shares in issue for the year.

 

 

 

 

 

 

 

Year ended

Year ended

 

 

 

 

 

 

31 October 2020

31 October 2019

Basic loss per share (pence)

 

 

 

 

 

(0.80)p

(0.68)p

Diluted loss per share (pence)

 

 

 

 

 

(0.80)p

(0.68)p

Loss attributable to equity Shareholders

 

 

 

 

 

£4,224,992

£2,850,840

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares in issue

 

 

 

 

 

528,865,765

418,024,570

 

Diluted earnings per share

As set out in note 18, there are share options and warrants outstanding as at 31 October 2020 which, if exercised, would increase the number of shares in issue. Given the losses for the year, there is no dilution of losses per share in the year ended 31 October 2020 nor the previous year.

 

11. INTANGIBLE ASSETS

 

 

 

 

 

 

 

 

 

 

Development costs

Patents

Commercial rights

Intangible assets

 

 

 

£

£

£

£

Cost

 

 

 

 

 

 

1 November 2018

 

 

-

680,113

-

680,113

Retirements

 

 

-

-

-

-

Additions

 

 

149,460

49,283

-

198,743

31 October 2019

 

 

149,460

729,396

-

878,856

Retirements

 

 

-

-

-

-

Additions

 

 

79,583

70,309

121,350

271,242

31 October 2020

 

 

229,043

799,705

121,350

1,150,098

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortisation

 

 

 

 

 

 

1 November 2018

 

 

-

237,427

-

237,427

Retirements

 

 

-

-

-

-

Charge for the year

 

 

-

35,388

-

35,388

31 October 2019

 

 

-

272,815

-

272,815

Retirements

 

 

-

-

-

 

Charge for the year

 

 

28,138

70,775

9,101

108,014

31 October 2020

 

 

28,138

343,590

9,101

380,829

 

 

 

 

 

 

 

Net book value 31 October 2019

 

 

149,460

456,581

-

606,041

Net book value 31 October 2020

 

 

200,905

456,115

112,249

769,269

 

 The commercial rights include the global preferential rights to integrate the HiiRoc plasma-based technology which were acquired by an initial payment in shares of £ 100,000 and future payments in kind through the provision of technical support.

 

 

 

12. RIGHT of uSE ASSETS

 

 

Buildings

 

£

1 November 2018

-

Adoption of IFRS 16

475,971

Additions

-

Disposals

-

1 November 2019

475,971

Additions

-

Disposals

-

31 October 2020

475,971

 

 

Depreciation

 

1 November 2018

-

Charge for the year

114,233

Disposals

-

1 November 2019

114,233

Charge for the year

114,233

Disposals

-

31 October 2020

228,466

 

 

Net Book Value

 

31 October 2019

361,738

31 October 2020

247,505

 

 

13. TANGIBLE FIXED ASSETS

 

 

Leasehold improvements

Decommissioning Asset

Fixtures, fittings and equipment

Motor vehicles

 

Demonstration equipment

Rental asset

Total

 

£

£

£

£

 

£

£

£

Cost

 

 

 

 

 

 

 

 

1 November 2018

337,462

301,172

1,297,742

17,994

 

-

-

1,954,370

Additions

-

-

30,849

-

 

193,404

-

224,253

Disposals

(115,950)

-

(3,800)

-

 

-

-

(119,750)

1 November 2019

221,512

301,172

1,324,791

17,994

 

193,404

-

2,058,873

Additions

-

-

161,697

-

 

133,571

423,138

718,406

Disposals

-

-

-

-

 

 

-

-

31 October 2020

221,512

301,172

1,486,488

17,994

 

326,975

423,138

2,777,279

 

 

 

 

 

 

 

 

 

Depreciation

 

 

 

 

 

 

 

 

1 November 2018

337,462

170,486

1,135,432

17,994

 

-

-

1,661,374

Charge for the year

-

31,364

88,950

-

 

-

-

120,314

Disposals

(115,950)

-

(3,800)

-

 

-

-

(119,750)

1 November 2019

221,512

201,850

1,220,582

17,994

 

-

-

1,661,938

Charge for the year

-

31,365

89,801

-

 

53,957

-

175,123

Disposals

-

-

-

-

 

-

-

-

31 October 2020

221,512

233,215

1,310,383

17,994

 

53,957

-

1,837,061

 

 

 

 

 

 

 

 

 

Net Book Value

 

 

 

 

 

 

 

 

1 November 2019

-

99,322

104,209

-

 

193,404

-

396,935

31 October 2020

-

67,957

176,105

-

 

273,018

423,138

940,218

 

 

 

 

 

 

 

 

 

          

 

The Company has set-up a decommissioning asset for the removal of the plant and equipment installed at the Stade site in Germany and for dilapidations associated with the leasehold premises at Dunsfold in the UK, the cost of which is based on estimates. No decision has been taken about the date when the plant will be decommissioned.

 

Minimum lease payments receivable on rental assets are £ 200,000 (2019: £ nil) of which £ 150,000 mature within twelve months and £ 50,000 between one and two years.

 

 

 

14. INVESTMENT

 

The previously held investment in the unlisted share capital of Waste2Tricity Ltd (a registered company in England & Wales) was sold on 12 March 2019 for £20,000. Simultaneously, the licence agreements with Waste2Tricity Limited and Waste2Tricity International (Thailand) Limited were terminated and £ 80,000 compensation was received in the current period. The investment in Waste2Tricity was fully provided and due to the lack of overwhelming evidence that the financial position had improved the recovery of the provision has been recognized when proceeds were received.

 

15. INVENTORY

 

 

 

 

 

 

Year ended

Year ended

 

 

 

 

 

 

31 October 2020

31 October 2019

 

 

 

 

 

 

£

£

Inventory

 

 

 

 

 

249,370

95,423

 

 

16. RECEIVABLES

 

 

 

 

 

 

Year ended

Year ended

 

 

 

 

 

 

31 October 2020

31 October 2019

 

 

 

 

 

 

£

£

Current:

 

 

 

 

 

 

 

Accounts receivable

 

 

 

 

 

60,000

13,941

R&D tax credits receivable

 

 

 

 

 

518,099

602,995

EU grants receivable

 

 

 

 

 

106,642

106,642

Other receivables

Prepayments

 

 

 

 

 

204,367

154,772

136,068

292,352

 

 

 

 

 

 

1,043,880

1,151,998

 

There is no significant difference between the fair value of the receivables and the values stated above.

 

 

 

 

17. CASH AND CASH EQUIVALENTS

 

 

 

 

 

 

Year ended

Year ended

 

 

 

 

 

 

31 October 2020

31 October 2019

 

 

 

 

 

 

£

£

Cash at bank

 

 

 

 

 

286,578

718,057

Bank deposits

 

 

 

 

 

31,014,889

609,878

 

 

 

 

 

 

31,301,467

1,327,935

 

Cash at bank and bank deposits consist of cash. There is no material foreign exchange movement in respect of cash and cash equivalents.

 

Restricted cash, not included in cash and cash equivalents, is €300,000 held in escrow to support a bank guarantee in favour of Air Products GmbH relating to contractual obligations by the Company in relation to the Stade site in Germany.

 

18. ISSUED SHARE CAPITAL

 

 

 

 

 

Ordinary shares

Share premium

Total

 

 

 

 

Number

£

£

£

Issue of shares 18 November 2019

 

 

 

2,600,000

2,600

517,400

520,000

Issue of shares 20 January 2020

 

 

 

5,882,353

5,882

994,118

1,000,000

Issue of shares 22 January 2020

 

 

 

5,882,353

5,882

994,118

1,000,000

Issue of shares 31 January 2020

 

 

 

526,316

526

99,474

100,000

Issue of shares 13 March 2020

 

 

 

483,332

483

38,184

38,667

Issue of shares 23 March 2020

 

 

 

14,000,000

14,000

1,386,000

1,400,000

Exercise of options 9 June 2020

 

 

 

550,000

550

113,575

114,125

Exercise of options 9 June 2020

 

 

 

37,500

38

5,737

5,775

Exercise of options 11 June 2020

 

 

 

40,000

40

6,120

6,160

Exercise of options 25 June 2020

 

 

 

500,000

500

103,250

103,750

Issue of shares 3 July 2020

 

 

 

24,364,875

24,365

3,874,015

3,898,380

Issue of shares 6 July 2020

 

 

 

71,107,125

71,107

11,306,033

11,377,140

Issue of shares 15 July 2020

 

 

 

625,000

625

99,375

100,000

Issue of shares 20 July 2020

 

 

 

101,403,000

101,403

16,123,077

16,224,480

Exercise of options 29 September 2020

 

 

 

16,666

17

1,450

1,467

Cost of shares issued

 

 

 

 

 

(1,633,505)

(1,633,505)

Issued share capital

 

 

 

228,018,520

228,018

34,028,421

34,256,439

31 October 2019

 

 

 

447,987,790

447,988

47,389,424

47,837,412

31 October 2020

 

 

 

676,006,310

676,006

81,417,845

82,093,851

          

 

The issue of shares on 31 January 2020 were part payment for certain commercial rights received in exchange for funding HiiRoc scaling up programme. The total consideration was £ 100,000 in shares plus future technical support up to £ 300,000.

 

All issued shares are fully paid. The Company considers its capital and reserves attributable to equity Shareholders to be the Company's capital. In managing its capital, the Company's primary long-term objective is to provide a return for its equity Shareholders through capital growth. Going forward the Company will seek to maintain a gearing ratio that balances risks and returns at an acceptable level and to maintain a sufficient funding base to enable the Company to meet its working capital needs. The Company's commercial activities are at an early stage and management considers that no useful target debt to equity gearing ratio can be identified at this time.

 

Details of the Company's capital are disclosed in the statement of changes in equity.

 

There have been no other significant changes to the Company's management objectives, policies and processes in the year nor has there been any change in what the Company considers to be capital.

 

19. Share BASED PAYMENTS

 

Employee Share Option Plan

The establishment of the Employee Share Option Plan was approved by the Board on 1 August 2018 and amended on 10 October 2018. The Plan is designed to attract, retain and motivate employees. Under the Plan, participants can be granted options which vest unconditionally or conditioned upon achieving certain performance targets. Participation in the Plan is solely at the Board's discretion and no employee has a contractual right to participate in the Plan or to receive any guaranteed benefits.

 

Options are granted under the Plan for no consideration and carry no dividend nor voting rights.

 

When exercisable, each option is convertible into one ordinary share.

 

Set out below are summaries of options granted under the Plan

 

 

Average exercise price per share option (£)

Number of options

Average exercise price per share option (£)

Number of options

 

2020

2020

2019

2019

1 November 2019

0.33

11,745,000

0.31

13,330,000

Granted during the year

0.16

4,885,000

 

-

Exercised during the year

0.17

(1,627,498)

0.03

(300,000)

Lapsed during the year

0.30

(581,667)

0.24

(1,285,000)

31 October 2020

0.30

14,420,835

0.33

11,745,000

Vested and exercisable at 31 October 2020

 

 

3,386,666

 

 

 

 

Share options outstanding at the end of the year have the following expiry dates and exercise prices.

 

Grant date

Expiry date

Exercise price (£)

Share options

Share options

 

 

 

2020

2019

17 April 2009

17 April 2019

0.0313

-

90,000

13 April 2010

13 April 2020

0.24

-

75,000

7 July 2010

6 July 2020

0.2075

-

1,050,000

7 November 2012

7 November 2022

0.3575

170,000

170,000

2 December 2013

1 December 2023

0.34

135,000

135,000

14 April 2015

13 April 2025

0.41

150,000

150,000

17 July 2015

17 July 2025

0.51

6,000,000

6,000,000

10 September 2018

1 August 2024

0.088

658,335

1,575,000

15 October 2018

15 October 2024

0.16

2,500,000

2,500,000

31 December 2019

20 April 2030

0.1635

2,750,000

0

20 April 2020

20 April 2030

0.154

2,057,500

0

 

 

 

14,420,835

11,745,000

 

 

 

The assessed fair value at grant date of options granted during the year ended 31 October 2020 was

 

Option price (pence)

Average grant date share price (pence)

Average expected volatility (per annum)

Average risk-free interest rate (per annum)

Average dividend yield (per annum)

Average implied option life (years)

Average fair value per option (pence)

Amount expensed in 2020 (£)

8.8

6.58

81.2%

0.80%

0%

1

2.2

15,500

15.4

14.9

99.6%

0.11%

0%

1.5

6.9

45,649

16.35

16.35

95,5%

0.54%

0%

2.0

8.1

74,443

Total charge for the year (2019: £ (549,227))

 

 

 

 

 

 

 

135,593

 

Warrants

The Board has the discretion to award warrants from time to time to third parties. Typically, warrants are granted and vest upon certain performance targets. Grant of warrants is solely at the Board's discretion.

 

Warrants are granted for no consideration and carry no dividend nor voting rights.

 

When exercisable, each warrant is convertible into one ordinary share.

 

Set out below are summaries of warrants granted under the Plan

 

 

Average exercise price per warrant (£)

Number of warrants

Average exercise price per warrant (£)

Number of warrants

 

2020

2020

2019

2019

1 November 2019

0.14

5,793,800

0.15

4,643,800

Granted during the year

0.20

4,500,000

0.05

3,000,000

Exercised during the year

 

 

 

 

Lapsed during the year

0.14

(5,793,800)

0.03

(1,450,000)

31 October 2020

0.20

4,500,000

0.14

5,793,800

Vested and exercisable at 31 October 2020

 

 

-

 

 

 

Warrants outstanding at the end of the year have the following expiry dates and exercise prices.

 

Grant date

Expiry date

Exercise price (£)

Share options

Share options

 

 

 

2020

2019

13 April 2010

13 April 2020

0.24

-

2,793,800

24 June 2019

24 June 2021

0.048

-

3,000,000

19 October 2020

31 January 2021

0.185

1,500,000

-

19 October 2020

13 October 2021

0.195

1,000,000

-

19 October 2020

13 April 2022

0.21

1,000,000

-

19 October 2020

13 October 2022

0.23

1,000,000

-

 

 

 

4,500,000

5,793,800

 

 

The assessed fair value at grant date of warrants for the year ended 31 October 2020 was nil (2019: £ 5,486)

SAYE

No SAYE were granted and the scheme ended during the period. The movements were

 

 

Average exercise price per SAYE (£)

Number of SAYE

Average exercise price per SAYE (£)

Number of SAYE

 

2020

2020

2019

2019

1 November 2019

0.12

207,736

0.12

207,736

Granted during the year

 

-

 

-

Exercised during the year

 

-

 

-

Lapsed during the year

0.12

(207,736)

 

-

31 October 2020

 

 

0.12

207,736

Vested and exercisable at 31 October 2020

 

-

 

 

 

SAYE outstanding at the end of the year have the following expiry dates and exercise prices.

 

Grant date

Expiry date

Exercise price (£)

Share options

Share options

 

 

 

2020

2019

28 April 2016

28 April 2019

0.122

-

207,736

 

 

 

-

207,736

Share based payment charge

 

 

2020

2019

 

£

£

Employee Share Option Plan

135,593

(549,227)

Warrants

-

-

SAYE

-

5,486

 

135,593

(543,741)

 

20. PAYABLES

 

 

 

 

 

 

Year ended

Year ended

 

 

 

 

 

 

31 October 2020

31 October 2019

 

 

 

 

 

 

£

£

Current liabilities:

 

 

 

 

 

 

 

Trade payables

 

 

 

 

 

347,167

298,590

Advance payments

 

 

 

 

 

150,000

28,187

Other payables

 

 

 

 

 

199,261

182,096

Accruals

 

 

 

 

 

540,368

158,938

 

 

 

 

 

 

1,236,796

667,811

 

21. LEASE LIABILITIES

 

 

Year ended

 31 October 2020

Year ended

31 October 2019

 

£

£

Lease liabilities less than 12 months

113,431

113,431

Lease liabilities more than 12 months

146,368

259,799

 

259,799

373,230

 

22. PROVISIONS

 

 

 

 

 

 

2020

2019

 

 

 

 

 

 

Decommissioning provision

Decommissioning provision

 

 

 

 

 

 

£

£

Non-current liabilities:

 

 

 

 

 

 

 

1 November

 

 

 

 

 

301,172

301,172

Addition

 

 

 

 

 

-

-

Utilisation

 

 

 

 

 

-

-

31 October

 

 

 

 

 

301,172

301,172

 

The Company has set-up a decommissioning provision associated with a commitment to remove the plant and equipment installed at the Stade site in Germany at a future date.

 

23. FINANCIAL INSTRUMENTS

In common with other businesses, the Company is exposed to risks that arise from its use of financial instruments. This note describes the Company's objectives, policies and processes for managing those risks and the methods used to measure them. Further quantitative information in respect of these risks is presented throughout these financial statements.

 

Principal Financial Instruments

The principal financial instruments used by the Company, from which financial instrument risk arises, are as follows:

 

 

 

 

 

 

 

Year ended

Year ended

 

 

 

 

 

 

31 October 2020

31 October 2019

 

 

 

 

 

 

£

£

Financial instruments held at amortised cost:

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

31,014,889

1,327,935

Receivables

 

 

 

 

 

1,043,880

1,151,998

Total financial assets held at amortised cost

 

 

 

 

 

32,058,769

2,479,933

Other payables

 

 

 

 

 

1,496,595

1,041,041

Total financial liabilities held at amortised cost

 

 

 

 

 

1,496,595

1,041,041

 

Financial instruments that are measured subsequent to initial recognition at fair value are grouped into three levels based on the degree to which the fair value is observable as defined by IFRS 7:

• Level 1 fair value measurements are those derived from unadjusted quoted prices in active markets for identical assets and liabilities.

• Level 2 fair value measurements are those derived from inputs, other than quoted prices included within Level 1, that are observable either directly (i.e. as prices) or indirectly (i.e. derived from prices); and

• Level 3 fair value measurements are those derived from valuation techniques that include inputs for the asset or liability that are not based on observable market data.

 

All financial instruments are Level 1 and none have been transferred between Levels during the year.

 

General Objectives, Policies and Processes

The Board has overall responsibility for the determination of the Company's risk management objectives and policies and, while retaining ultimate responsibility for them, it has delegated part of the authority for designing and operating processes that ensure the effective implementation of the objectives and policies to the Company's finance team. The Board receives reports from the financial team through which it reviews the effectiveness of the processes put in place and the appropriateness of the objectives and policies it sets.

 

The overall objective of the Board is to set policies that seek to reduce ongoing risk as far as possible without unduly affecting the Company's competitiveness and flexibility. Further details regarding these policies are set out below.

 

Credit Risk

Credit risk arises principally from the Company's other receivables and cash and cash equivalents. It is the risk that the counterparty fails to discharge its obligation in respect of the instrument. The maximum exposure to credit risk equals the carrying value of these items in the financial statements as shown below:

 

 

 

 

 

 

 

Year ended

Year ended

 

 

 

 

 

 

31 October 2020

31 October 2019

 

 

 

 

 

 

£

£

Receivables

 

 

 

 

 

1,043,880

1,151,998

Cash and cash equivalents

 

 

 

 

 

31,014,889

1,327,935

 

The Company's principal other receivables arose from: a) VAT receivable from UK and German tax authorities b) an R&D tax credit c) grant funding receivable from the EU. Credit risk with cash and cash equivalents is reduced by placing funds with banks with acceptable credit ratings and government support where applicable and on term deposits with a range of maturity dates. At the year end, most cash were temporarily held on short-term deposit.

 

Liquidity Risk

Liquidity risk arises from the Company's management of working capital and the amount of funding required for the development programme. It is the risk that the Company will encounter difficulty in meeting its financial obligations as they fall due. The Company's policy is to ensure that it will always have sufficient cash to allow it to meet its liabilities when they become due.

 

The principal liabilities of the Company are trade and other payables in respect of the ongoing product development programme. Trade payables are all payable within two months. The Board receives cash flow projections on a regular basis as well as information on cash balances.

 

Interest Rate Risk

The Company is exposed to interest rate risk in respect of surplus funds held on deposit and, where appropriate, uses fixed interest term deposits to mitigate this risk.

 

Fair Value of Financial Liabilities

 

 

 

 

 

 

Year ended

Year ended

 

 

 

 

 

 

31 October 2020

31 October 2019

 

 

 

 

 

 

£

£

Trade and other payables

 

 

 

 

 

1,236,796

667,811

Lease liabilities less than one year

 

 

 

 

 

113,431

113,431

Lease liabilities more than one year

 

 

 

 

 

146,368

259,799

 

 

 

 

 

 

1,496,595

1,041,041

 

There is no difference between the fair value and book value of trade and other payables and provisions.

 

The Company does not enter into forward exchange contracts or otherwise hedge its potential foreign exchange exposure. The Board monitors and reviews its policies in respect of currency risk on a regular basis.

 

24. CAPITAL COMMITMENTS AND OTHER OBLIGATIONS

The Company had no capital commitments outstanding at 31 October 2020 (2019: £nil).

 

The aggregate amount of the transaction price allocated to contracts that are fully unsatisfied as at 31 October 2020 was £ 354,000 (2019: £ nil). The Company expects to recognise these revenues within the next twelve months.

 

25. FINANCING FACILITIES

On 11 April 2019, a £4 million equity financing facility was signed for a period of 36 months from the signing date with a further six-month period, post the expiry date of the facility, to repay any outstanding amounts.

 

 

 

26. EVENTS AFTER THE REPORTING PERIOD

After the reporting date

· the financing facility was terminated by mutual agreement. No drawdowns had been made on the facility, and

· the vesting conditions of Adam Bond's share options were reviewed and amended by the Remuneration committee.

o The target prices were adjusted to 42.5p, 64p and 85p (respectively) to take into account the change in the share capital since July 2015. 

o A retention clause was added to these options such that a specified number of shares should not be sold between the date of exercise and the first anniversary of these revisions. This holding requirement is reduced by the number of shares necessary to meet the tax liability arising from the exercise of the options.

o The operational performance conditions for all but one of the original targets have either been achieved, or a comparable measure achieved. The exercise price of these options has been adjusted from 51p to 22p, in line with changes in the share capital since July 2015.

 

27. ULTIMATE CONTROLLING PARTY

There is no ultimate controlling party.

 

 

 

[1] Taken from Hydrogen Council/McKinsey report, 'A perspective on Hydrogen Investment, Deployment and Cost Competitiveness' (February 2021)

[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498239/

[3] Taken from https://about.bnef.com/electric-vehicle-outlook/ 

[4] Taken from https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/882196/vehicle-licensing-statistics-2019.pdf 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR MZGZZNVKGMZM
Date   Source Headline
25th Apr 20242:00 pmRNSAGM Results and Appointment of SID
25th Apr 202412:00 pmRNSBlock Listing Return
10th Apr 20247:00 amRNSNotice of Capital Markets Event
28th Mar 20241:00 pmRNSNotice of 2024 AGM
26th Mar 20247:00 amRNSQ&A session via Investor Meet Company
15th Mar 20241:00 pmRNSTotal Voting Rights
14th Mar 20247:00 amRNSS Series Fuel Cell Operating Cost Milestone
11th Mar 20247:00 amRNSFirst Factory Acceptance Test of 30kW Generator
4th Mar 20247:00 amRNSGenerator Attestation of Conformity for CE Mark
28th Feb 20247:00 amRNSAmmonia Cracker Milestones Achieved
26th Jan 20247:00 amRNSFunding Secured for Maritime Ammonia Cracker Trial
18th Dec 20237:00 amRNSAppointment of Additional Corporate Broker
4th Dec 20237:00 amRNSWorld First Ammonia Cracking Pilot
17th Nov 20237:00 amRNSPurchase of Assets from Octopus Hydrogen
15th Nov 20237:00 amRNSLaunch of Speedy Hydrogen Solutions & First Orders
25th Oct 20237:00 amRNSBlock Listing Return and Correction
23rd Oct 202312:00 pmRNSLaunch of 2023 SAYE Scheme
23rd Oct 20237:00 amRNSAmmonia Cracker Technology Milestone Achieved
4th Sep 20237:00 amRNSExclusive Distribution Agreement with TAMGO
8th Aug 202310:41 amRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSInterim Results
28th Jul 20237:00 amRNSProposed Launch of Speedy Hire Joint Venture
27th Jul 20237:00 amRNSAppointment of Non-Executive Director
26th Jul 20237:00 amRNSAFC Energy Secures £4.3m UK Government Grant
18th Jul 20237:00 amRNSStade Update
16th Jun 20232:01 pmRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSBoard Changes
1st Jun 20233:52 pmRNSDirector/PDMR Shareholding
1st Jun 20237:00 amRNSGrant of Share Options
11th May 20237:00 amRNSNon-Executive Director Retirement
2nd May 20239:25 amRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSGrant of Options
28th Apr 20237:00 amRNSNotice of Investor Presentation
28th Apr 20237:00 amRNSAnnual General Meeting Results
25th Apr 20233:58 pmRNSBlock Listing Return
21st Apr 20236:03 pmRNSAnnual Financial Report
19th Apr 20237:00 amRNSACCIONA Orders First 50kVA H-Power Generator
4th Apr 20237:00 amRNSNotice of AGM
29th Mar 20237:05 amRNSABB E-mobility Follow On Investment
29th Mar 20237:00 amRNSABB Milestone Validation
23rd Mar 20237:00 amRNS“Ammonia to Hydrogen” Cracker Technology Launch
9th Mar 20237:00 amRNSH-Power Tower Deployment Update
7th Mar 20237:00 amRNSAppointment of New Business Development Manager
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
1st Dec 20227:00 amRNSPeter Dixon Clarke Appointment
23rd Nov 202211:49 amRNSHS2 Fuel Cell Tower
7th Nov 20227:00 amRNSMethanol Fuel Tower Field Trial
3rd Oct 20227:00 amRNSACCIONA Power Tower Deployment
29th Sep 20227:02 amRNSAppointment of Chief Financial Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.